id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-339355-zkkj8a83	Siripanthong, Bhurint	Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure	2020-07-01		.txt	text/plain	2327	97	30	In cardiology, COVID-19 has imposed an unfortunate conundrum: the disease is significantly associated with death in patients with pre-existing cardiovascular disease, [1, 2] and yet hospital admissions and certain cardiac procedures have significantly declined compared with prior years [3] [4] [5] . This creates a potentially multiplicative problem if COVID-19 and its etiologic virus, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), directly or indirectly cause increased cardiac damage while patients with cardiac disease are simultaneously undertreated for pre-existing or de novo illness. In spite of numerous mechanisms that may increase the likelihood or severity of cardiovascular disease in COVID-19, many centers have thus far reported a decline in the number of patients admitted for the acute coronary syndrome (ACS). Furthermore, the way in which certain centers approach the diagnosis of ACS or myocardial infarction in COVID-19 patients may have contributed to the decline in the apparent incidence of ischemic heart disease.	./cache/cord-339355-zkkj8a83.txt	./txt/cord-339355-zkkj8a83.txt